<DOC>
	<DOCNO>NCT01225653</DOCNO>
	<brief_summary>Randomized double-blinded two-year intervention study topical application latanoprost placebo eye drop patient diabetic retinopathy .</brief_summary>
	<brief_title>Topical Application Latanoprost Diabetic Retinopathy</brief_title>
	<detailed_description>The primary objective study sustain contraction pathologically dilate retinal arteriole obtain . Retinal arteriolar diameter diameter response increase blood pressure study use Dynamic Vessel Analyzer ( Imedos , Germany . The secondary objective study whether intervention halt development diabetic retinopathy , assess optical coherence tomography ( OCT ) scan fundus photography .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Age 2036 year old Diabetes mellitus retinopathy Pregnancy Previous ocular disease diabetic retinopathy General disease possible influence eye</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Latanoprost</keyword>
	<keyword>vasodilation</keyword>
	<keyword>diabetic retinopathy</keyword>
</DOC>